Papillary Thyroid Cancer: Radiographic SLNB May Lead to Management Change
The use of the radioguided sentinel lymph node biopsy (rSLNB) technique may lead to management change in more than 33% of patients with papillary thyroid cancer.
The use of the radioguided sentinel lymph node biopsy (rSLNB) technique may lead to management change in more than 33% of patients with papillary thyroid cancer.
Cowden syndrome (CS)/CS-like patients with PTEN mutations, SDHx variations, and KLLN epimutations are at increased risk of epithelial thyroid cancers.
A look at the following clinical trial: Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
A look at the following clinical trial: Pazopanib in Treating Patients With Advanced Thyroid Cancer
A look at the following clinical trial: Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
A look at the following clinical trial: Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer (Panthera)
Please login or register first to view this content.